Skip to content

Ultrasound-CT Fusion System for Interventional Radiology Procedures

Ultrasound-CT Fusion System for Interventional Radiology Procedures

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03226535
Enrollment
20
Registered
2017-07-21
Start date
2017-06-22
Completion date
2018-06-22
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Guided Biopsy, CT Guided Drain Placement Within the Abdomen or Pelvis, CT Guided Injection of Muscle or Nerve Within the Pelvis

Keywords

Computer Assisted Instrument Guidance (CAIG), Ultrasound-CT Fusion, Image Fusion, Clear Guide SCENERGY, Needle path, Needle Guidance, CT, Ultrasound

Brief summary

The objective of this research is to use the Clear Guide SCENERGY technology, an FDA approved Ultrasound-CT fusion imaging system, that allows the user to fuse CT images onto a real-time ultrasound that is being performed on the patient. This fusion system will be used to perform ultrasound guided needle placements for patients undergoing percutaneous CT guided needle-based intervention. This study will consist of 20 patients, 10 patients using the CGM SCENERGY US-CT system and 10 patients using guidance only. The primary goal of the study is to prove that the new imaging fusion system is comparable to using either CT or US guidance alone to guide needle placement.

Detailed description

A simple 20 patient study will be performed using the CG SCENERGY system. This fusion system will be used to perform image guided needle placements for patients undergoing percutaneous CT guided needle-based intervention (CT guided biopsy, CT guided drain placement within the abdomen or pelvis, and CT guided injection of muscle or nerve within the pelvis). Only patients who are already scheduled for a CT guided procedure will be screened. The study design is as follows: * 10 patients will have their procedure performed using the CGM SCENERGY US-CT fusion system and 10 patients will have their procedure performed using CT guidance only. * Proper informed consent will be obtained * Perform a CT scan with the optical adhesive skin markers in place. Markers are placed around the expected site of needle skin entry. * The first 10 patients Group#1 (1-10) will be assigned to using the SCENERGY fusion system to complete the needle placement, and the next 10 patients Group #2 (11-20) will be assigned of continuing with CT guidance only to complete the needle placement. * If in Group #1, the procedure will proceed as usual using the SCENERGY system to guide the needle to target. If in the Group #2, CT guidance will be used to place the needle to target. * Once the needle is at the target, a confirmatory CT will be performed. * If the target is reached (i.e., the software directed the interventional radiologist to the right place, e.g. for correctly biopsying a lesion), the trial is considered a success and the procedure continues as normal. * If the needle is not in the right place, the trial is considered a failure, and the procedure continues as normal without using the CGM software any further.

Interventions

DEVICEUltrasound-CT Fusion

The Clear Guide SCENERGY is an Ultrasound-CT fusion device which supplements existing ultrasound and CT capabilities. The participants randomly selected (out of 20 patients) for use of the Clear Guide SCENERGY (test group) will receive ultrasound-CT fusion guidance from the MDs performing the procedure.

Sponsors

Johns Hopkins University
CollaboratorOTHER
Clear Guide Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing percutaneous CT guided needle-based intervention (CT guided biopsy, CT guided drain placement within the abdomen or pelvis, and CT guided injection of muscle or nerve within the pelvis) * Able to give written informed consent

Exclusion criteria

* Unable to give informed consent * Patients undergoing CT guided needle-based interventions other than the procedures mentioned in the inclusion criteria * Prisoners, pregnant women, and children

Design outcomes

Primary

MeasureTime frame
Number of CT scans or CT fluoroscopic imagesImmediately following intervention (within 2 hours)

Secondary

MeasureTime frameDescription
Total procedure timeImmediately following intervention (within 2 hours)Time from the first CT scan until the needle is at the target
Time to targetImmediately following intervention (within 2 hours)Time from needle entering the skin until the needle is at the target
Success of needle placementImmediately following intervention (within 2 hours)A confirmatory CT will be performed to check if the needle reached the target

Countries

United States

Contacts

Primary ContactBrian Holly, MD
bholly3@jhmi.edu410-614-1622
Backup ContactTaylor Dunklin, DA
tdunkli1@jhmi.edu410-502-5118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026